CRST: The Podcast Podcast Por Cataract and Refractive Surgery Today arte de portada

CRST: The Podcast

CRST: The Podcast

De: Cataract and Refractive Surgery Today
Escúchala gratis

Join CRST: The Podcast at the intersection of patient care and innovation in ophthalmology and listen as experts in the field engage in thought-provoking discussion on anterior segment surgery. This podcast curates content and mini series that help progressive cataract and refractive surgeons take their practices to the next level. CRST: The Podcast is produced by Bryn Mawr Communications and the medical trade publication Cataract & Refractive Surgery Today.2024 Bryn Mawr Communications LLC Ciencia Ciencias Biológicas
Episodios
  • Refractive Innovation in Private Practice
    Jul 9 2025
    Neda Shamie, MD, sits down with George O. Waring IV, MD, FACS, for a conversation about his journey from academic medicine to founding the Waring Vision Institute in Charleston, South Carolina. They explore his philosophy toward refractive care, the origin and impact of the term dysfunctional lens syndrome, and how his practice uniquely blends research, surgical innovation, and patient-centered care.
    Más Menos
    31 m
  • Exploring the Launch of LACRIFILL® Canalicular Gel
    Jul 1 2025
    Jai Parekh, MD, MBA, FAAO, chief commercial officer for Nordic Pharma Inc., and Phil Gioia, president of Nordic Pharma Inc., invite Darrell White, MD, to share his real-world experiences with LACRIFILL® Canalicular Gel.
    Más Menos
    16 m
  • One-Year Clinical and Real-World Outcomes with the TENEO Excimer
    Jun 20 2025
    In this episode, Drs. Waring and Chu share clinical insights and real-world experience from the first year of using the Teneo 317 excimer laser for correcting myopia and myopic astigmatism. As the first excimer platform to receive FDA approval in over 15 years, the Teneo 317 introduces modern performance to U.S. practices with its compact design, fast ablation speed, and intuitive user interface. The conversation covers key findings from the FDA clinical trial and early post-market use, including exceptional visual acuity outcomes, improved night vision, and high levels of patient satisfaction. Sponsored by Bausch + Lomb©2025 Bausch + Lomb TEN.0014.USA.25
    Más Menos
    38 m
Todavía no hay opiniones